AG
Artal Group Portfolio holdings
AUM
$930M
1-Year Return
3.57%
This Quarter Return
+5.69%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$3.88B
AUM Growth
+$183M
(+4.9%)
Cap. Flow
+$10.3M
Cap. Flow
% of AUM
0.27%
Top 10 Holdings %
Top 10 Hldgs %
90.38%
Holding
98
New
16
Increased
18
Reduced
14
Closed
4
Top Buys
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$15.9M |
| 2 |
MetLife
MET
|
$10.6M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$10.1M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$7.69M |
| 5 |
Neurocrine Biosciences
NBIX
|
$7.58M |
Top Sells
| 1 |
Incyte
INCY
|
$43.4M |
| 2 |
BLUE
bluebird bio
BLUE
|
$15.7M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.1M |
| 4 |
CELG
Celgene Corp
CELG
|
$11.6M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$10.3M |
Sector Composition
| 1 | Consumer Staples | 52.04% |
| 2 | Healthcare | 33.12% |
| 3 | Consumer Discretionary | 12.51% |
| 4 | Financials | 0.85% |
| 5 | Industrials | 0.32% |
